Clinical Trials Browser

Recruiting × Carcinoma, Non-Small-Cell Lung × camrelizumab × Clear all

NCT06241807 2024-02-14

Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT05825443 2023-04-25

PANORAMA

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung